Trial Profile
A randomized controlled trial of alteplase (rt-PA) vs standard treatment in acute ischemic hemispheric stroke in patients aged more than 80 years where thrombolysis is initiated within 3 hours after stroke onset.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 17 Aug 2011
Price :
$35
*
At a glance
- Drugs Alteplase (Primary)
- Indications Embolism and thrombosis; Stroke
- Focus Adverse reactions; Therapeutic Use
- 17 Aug 2011 New trial record